According to Citi analysts, Amgen’s acquisition of Dark Blue could further drive the strength of Amgen’s early oncology ...

Nimbus will apply its computational chemistry and structure-based drug design to a discovery programme in obesity treatment.

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

Experts say OADs, insulin to dominate anti-diabetes market, with semaglutide patent loss leading to possible price erosion, ...

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

Until recently, the popular weight loss treatment called Wegovy was only available in injection form. The newly-launched ...

China’s human weight-loss drug market targeting GLP-1 receptors has heated up in recent years, with both global and domestic ...

With generic versions of the weight-loss drug Ozempic expected to hit the Canadian market this year, provincial data shows ...

Novo Nordisk has launched an oral Wegovy pill in the U.S., offering a lower-cost alternative to injections and intensifying ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

Doctors explain how effective the first GLP-1 weight loss pill is, as well as its side effects, where to get it, and how much ...